Cargando…
Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
BACKGROUND: Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%. However, evidence from trials for effi...
Autores principales: | Wasfy, Jason H, Achanta, Aditya, Hidrue, Michael K, Urbut, Sarah, Axtell, Andrea L, Berman, Adam N, Zhao, Yunong, Chen, Julian, Gustus, Sarah, Picard, Michael H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462974/ https://www.ncbi.nlm.nih.gov/pubmed/37625819 http://dx.doi.org/10.1136/openhrt-2023-002289 |
Ejemplares similares
-
Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study
por: Stoevelaar, Rik, et al.
Publicado: (2020) -
Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
por: Prameswari, Hawani Sasmaya, et al.
Publicado: (2023) -
Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020) -
Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016) -
Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)